TW202404955A - 用於生產奧希替尼之改進方法 - Google Patents

用於生產奧希替尼之改進方法 Download PDF

Info

Publication number
TW202404955A
TW202404955A TW112112997A TW112112997A TW202404955A TW 202404955 A TW202404955 A TW 202404955A TW 112112997 A TW112112997 A TW 112112997A TW 112112997 A TW112112997 A TW 112112997A TW 202404955 A TW202404955 A TW 202404955A
Authority
TW
Taiwan
Prior art keywords
formula
compound
salt
reaction
acid
Prior art date
Application number
TW112112997A
Other languages
English (en)
Chinese (zh)
Inventor
亞歷山大 基龍 穆倫
亞歷山德羅 波佐利
Original Assignee
瑞典商阿斯特捷利康公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 瑞典商阿斯特捷利康公司 filed Critical 瑞典商阿斯特捷利康公司
Publication of TW202404955A publication Critical patent/TW202404955A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epidemiology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
TW112112997A 2022-04-07 2023-04-07 用於生產奧希替尼之改進方法 TW202404955A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263362622P 2022-04-07 2022-04-07
US63/362,622 2022-04-07

Publications (1)

Publication Number Publication Date
TW202404955A true TW202404955A (zh) 2024-02-01

Family

ID=86142780

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112112997A TW202404955A (zh) 2022-04-07 2023-04-07 用於生產奧希替尼之改進方法

Country Status (14)

Country Link
US (1) US20250250255A1 (https=)
EP (1) EP4504718A1 (https=)
JP (1) JP2025511404A (https=)
KR (1) KR20250002363A (https=)
CN (1) CN119317624A (https=)
AR (1) AR128999A1 (https=)
AU (1) AU2023250220A1 (https=)
CA (1) CA3255378A1 (https=)
CO (1) CO2024015096A2 (https=)
IL (1) IL316018A (https=)
MX (1) MX2024012370A (https=)
TW (1) TW202404955A (https=)
WO (1) WO2023194531A1 (https=)
ZA (1) ZA202408113B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120717920A (zh) * 2025-08-18 2025-09-30 爱斯特（成都）生物制药股份有限公司 一种微通道连续合成3-硝基-4-氟苯腈的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4119551A1 (en) 2011-07-27 2023-01-18 Astrazeneca AB 2-(2,4,5-substituted-anilino)pyrimidine compounds
CN106883216B (zh) * 2017-04-06 2020-03-13 张家港威胜生物医药有限公司 一种奥希替尼的制备方法
IN201741031902A (https=) * 2017-09-08 2019-03-15 Msn Laboratories Private Ltd
CN109134435B (zh) 2018-10-29 2023-01-03 湖南大学 一种奥希替尼azd9291的合成方法

Also Published As

Publication number Publication date
JP2025511404A (ja) 2025-04-15
CN119317624A (zh) 2025-01-14
AR128999A1 (es) 2024-07-03
ZA202408113B (en) 2025-07-30
KR20250002363A (ko) 2025-01-07
WO2023194531A1 (en) 2023-10-12
MX2024012370A (es) 2024-11-08
AU2023250220A1 (en) 2024-11-07
IL316018A (en) 2024-11-01
CO2024015096A2 (es) 2024-11-28
EP4504718A1 (en) 2025-02-12
CA3255378A1 (en) 2023-10-12
US20250250255A1 (en) 2025-08-07

Similar Documents

Publication Publication Date Title
US9233955B2 (en) Process for the preparation of azilsartan medoxomil
CN102985416B (zh) 制备凝血酶特异性抑制剂的方法
JP6126019B2 (ja) ２−エトキシ−１−（（２’−（（ヒドロキシアミノ）イミノメチル）ビフェニル−４−イル）メチル）−１Ｈ−ベンゾ［ｄ］イミダゾール−７−カルボン酸及びそのエステルの製造方法
CN103319483A (zh) 一种利拉列汀重要中间体的制备方法
JP2016117720A (ja) ２−アミノ−ｎ−（２，２，２−トリフルオロエチル）アセトアミドの調製方法
EP2707364B1 (en) Process for the manufacture of dabigatran etexilate and intermediates thereof
US20190241511A1 (en) Polymorphic forms of belinostat and processes for preparation thereof
TW202404955A (zh) 用於生產奧希替尼之改進方法
CN116535384A (zh) 替卡格雷中间体的制备方法
CN1194971C (zh) 2－丁基－1,3－二氮杂螺环[4.4]壬烷－1－烯－4－酮的改进的生产工艺
WO2020053795A2 (en) Process for the preparation of acalabrutinib and its intermediates
EP2888230A2 (en) An improved process for the preparation of atazanavir bisulfate
CN103298795A (zh) 用于制备来曲唑的纯中间体
AU2010313521B2 (en) Methods of preparing 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone
PL209540B1 (pl) Pochodna oksadiazabicyklooktanu
US20110071302A1 (en) Process for preparing intermediate compound for synthesizing an antiulcerant
WO2013001511A1 (en) Novel salt intermediates for the synthesis of bazedoxifene acetate and process thereof
CN104672239A (zh) 一种采用一锅法制备阿巴卡韦式v中间体的工艺
BR112012029363B1 (pt) Processo para preparar 1-alquil-3-difluorometil-5 -hidroxipirazóis
US20100174073A1 (en) Process for the preparation of alfuzosin and salts thereof
US9040697B2 (en) Process for the production of moxonidine
US20110144346A1 (en) Method for producing n-phenyl-n-(4-piperidinyl) amide salts
WO2022034427A1 (en) An improved process for the preparation of 4-oxoisotretinoin
JP2005194266A (ja) インドール類の合成方法および合成中間体
JP2006188505A (ja) インドール類の製造方法および製造中間体